A multi-institutional study led by researchers at Children's Hospital of Philadelphia (CHOP) is the first to identify one of the allergens responsible for eosinophilic esophagitis (EoE), an ...
The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...